Pirtobrutinib (LOXO-305, LY 3527727, RXC-005) is a highly selective and non-covalent next generation BTK inhibitor, which inhibits diverse BTK C481 substitution mutations. Pirtobrutinib is also more than 300-fold selective for BTK versus 370 other kinase
Molecular Weight:
479.43
Purity:
99.94%
CAS Number:
[2101700-15-4]
Formula:
C22H21F4N5O3
Target:
BTK
* VAT and and shipping costs not included. Errors and price changes excepted